InvestorsHub Logo

Bobwins

03/20/19 3:44 PM

#1111 RE: Bobwins #1110

looks like Oppenheimer conference wasn't a big deal for ACRX. Price actually went down after start of presentation.

Guess attendees weren't that excited about ACRX chances with new drug launch. May be in a show me stance due to Opiod negative publicity.